Trials / Sponsors / OncXerna Theraputics, Inc.
OncXerna Theraputics, Inc.
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | A Study of Navicixizumab in Patients With Platinum Resistant Ovarian Cancer Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma | Phase 3 | 2022-11-30 |
| Unknown | A Study of Navicixizumab Monotherapy or in Combination in Patients With Select Advanced Solid Tumors Colorectal Cancer, Triple Negative Breast Cancer, Gastric Cancer | Phase 2 | 2022-08-05 |
| Completed | An Open Label Study of Bavituximab and Pembrolizumab in Advanced Gastric and GEJ Cancer Patients Gastric Cancer, GastroEsophageal Cancer | Phase 2 | 2019-09-11 |